$63.110
+0.801 (+1.27%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
RPRX 相似圖表分析預測
Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $62.69 (-1.87%). The 1-week path is $63.38 (-0.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Royalty Pharma PLC 股票嗎?
Royalty Pharma PLC appears to be a good buy right now due to its strong financial performance, with a year-to-date change of +56.59% and a 1-year change of +68.23%. The company has also raised its full-year guidance to $3.4 billion to $3.5 billion, indicating robust growth potential. However, the main risk is its high forward P/E ratio of 47.85, which suggests that the stock may be overvalued if growth expectations do not materialize.
RPRX 股價於 Wednesday 收在 $63.11,此前上漲 +1.27%
Royalty Pharma PLC (RPRX) last closed at $63.88, gaining +1.22%. These facts feed the 1-day and 1-week RPRX price prediction above.
預測驅動因素
Royalty Pharma PLC(RPRX)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 RPRX 最接近的股票,依相似度排序。
RPRX 季節性分析
Historically the probability of a positive September return for RPRX is 63.64%. March offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。